Relmada TherapeuticsRLMD
那斯達克 · USD
6.73
+0.13
(+1.97%)
收盤 06/19 03:59 (UTC+8)
盤後
6.75
+0.02
(+0.30%)
06/19 03:59 (UTC+8)
Relmada TherapeuticsRLMD
6.73
+0.13
(+1.97%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 19,462 | 20,333 | 10,327 | 10,221 | 18,218 | 19,076 | - | - | 22,988 | 26,829 |
研發費用 | 8,088 | 8,072 | 4,036 | 2,819 | 11,951 | 11,000 | 11,149 | 10,721 | 13,305 | 14,752 |
推銷及管理費用 | 11,374 | 12,261 | 6,291 | 7,402 | 6,267 | 8,076 | 11,860 | 8,098 | 9,683 | 12,077 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -19,462 | -20,333 | -10,327 | -10,221 | -18,218 | -19,076 | -23,009 | -18,819 | -22,988 | -26,829 |
其他收入及費用 | 410 | 465 | 236 | 355 | 659 | 418 | 1,283 | 1,051 | 1,160 | 1,664 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -19,052 | -19,868 | -10,091 | -9,866 | -17,559 | -18,657 | -21,726 | -17,768 | -21,828 | -25,165 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -19,052 | -19,868 | -10,091 | -9,866 | -17,559 | -18,657 | -21,726 | -17,768 | -21,828 | -25,165 |
基本每股稅後盈餘(元) | -0.22 | -0.27 | -0.30 | -0.30 | -0.58 | -0.62 | -0.72 | -0.59 | -0.72 | - |
稀釋每股稅後盈餘(元) | -0.22 | -0.29 | -0.30 | -0.28 | -0.58 | -0.62 | -0.72 | -0.59 | -0.72 | -0.83 |
基本平均股數(千股) | 86596.00 | 61128.00 | 33191.00 | 33191.00 | 30408.00 | 30175.00 | 30174.00 | 30174.00 | 30132.00 | - |
稀釋平均股數(千股) | 86596.00 | 61128.00 | 33191.00 | 33191.00 | 30408.00 | 30175.00 | 30174.00 | 30174.00 | 30132.00 | - |
還原基本每股稅後盈餘(元) | -0.22 | -0.27 | -0.30 | -0.30 | -0.58 | -0.62 | -0.72 | -0.59 | -0.72 | - |
還原稀釋每股稅後盈餘(元) | -0.22 | -0.29 | -0.30 | -0.28 | -0.58 | -0.62 | -0.72 | -0.59 | -0.72 | -0.83 |
還原基本平均股數(千股) | 86,596 | 61,128 | 33,191 | 33,191 | 30,408 | 30,175 | 30,174 | 30,174 | 30,132 | - |
還原稀釋平均股數(千股) | 86,596 | 61,128 | 33,191 | 33,191 | 30,408 | 30,175 | 30,174 | 30,174 | 30,132 | - |
EBITDA(千元) | -19,052 | -19,868 | -10,091 | -9,866 | -17,559 | -18,657 | -21,726 | -17,768 | -21,828 | -25,165 |